Y-k M. Tse
Hong Kong, HCW, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis.
Journal: Alimentary pharmacology & therapeutics
Published: May 30, 2017
Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population.
Journal: Alimentary pharmacology & therapeutics
Published: February 20, 2017
Long-term use of oral nucleos(t)ide analogues for chronic hepatitis B does not increase cancer risk - a cohort study of 44 494 subjects.
Journal: Alimentary pharmacology & therapeutics
Published: November 24, 2016
Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma.
Journal: Alimentary pharmacology & therapeutics
Published: November 09, 2015
Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study.
Journal: Alimentary pharmacology & therapeutics
Published: May 19, 2015
Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B.
Journal: Alimentary pharmacology & therapeutics
Published: September 18, 2014
Aromatherapy: does it help to relieve pain, depression, anxiety, and stress in community-dwelling older persons?
Journal: BioMed research international
Published: February 11, 2014
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments.
Journal: Alimentary pharmacology & therapeutics
Published: September 29, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026